AU - Editor,: Scanlon,Kevin J. TI - Therapeutic applications of ribozymes SN - 0896034771 U1 - 616.042 PY - 0000/// CY - PB - KW - Hastalıklar KW - Diseases KW - Catalytic RNA--Therapeutic use KW - Katalitik RNA - Tedavi amaçlı kullanım KW - Catalytic RNA--Laboratory manuals KW - Katalitik RNA - Laboratuvar kılavuzları N1 - Includes index. (447-462 p.); Philip Hendry. Trevor J. Lockett, and Maxine J. McCall; Small Efficient Hammerhead Ribozymes; Arnold Hampel; The Hairpin Ribozyme: Discovery and Development for Gene Therapy; N.Kyle Tanner; Molecular Manipulations of the Catalytic RNAs From the Human Hepatitis; Lun-Quab Sun, Wayne Gerlach. and Geoff Symonds; The Design, Production , and Validation of an Anti-HIV Type 1 Ribozyme; Eric M. Poeschia, Mang Yu, Mark C. Leavitt. and Flossie Wong-Staal; Methods For Treating HIV by Gene Therapy Using Ribozymes; Jun Ohkawa, Yutaka Takebe, and Kazunari Taira; An Expression Vector for Multiple Ribozymes; Gerd Hobom and Annette Menke; Viral RNA Targets for Ribozymes : Influenza A virus; Fritz von Welzsacker, Hubert E.Blum, and Jack R. Wands; Hammerhead Ribozyme-Mediated Cleavage of Hepatitis B Virus RNA; Glenn H. Cantor; Bovine Leukemia Virus Ribozymes; David Y. Bouffard; Use of Ribozymes to Specifically Alter the MDR-1 Phenotype; Akira Irie, Jerry Tsai, and Mohammed Kashani -Sabet; Adenoviral-Mediated Anti-H-ras Ribozyme for the Treatment of Bladder Cancer; Tsukasa Ohkawa and Mohammed Kashani-Sabet; Tissue-Specific Delivery of an Anti-H-ras Ribozyme Against Malignant Melanoma; Hiroshi Kijima, David Y. Bouffard, and Kevin J. Scanlon; Ribozymes as a Novel Approach for the Treatment of Human Pancreatic Carcinoma; Alex W. Tong, Yu-An Zhang, John Nemunaitis and Gabriele Mues; K-ras Ribozyme for Lung Cancer; Toshiya Suzuki,Lisa D. Curclo, Jerry Tsai, and Mohammed Kashani-Sabet; Anti-C-erb-B-2 Ribozyme for Breast Cancer; Gunhild M Maelandsmo, Inge Kjonniksen, Elvind Hovig, Kevin J.Scanlon, and Oystein Fodstad; Ribozymes: Applications in Cancer Metastasis Research; Mouldy Sloud; Preformed Ribozymes: Strategies for Design and In Vivo Application as Anticytokine Agents; Lance H.Leopold, Scott K. Shore, Ramana M.V. Reddy and E. Premkumar Reddy; Folate-Polysine-Mediated Delivery of a Multiunit Anti-BAR/ABL Ribozyme to BCR/ABL-Transformed 32D Cells; Hiromichi Matsushita, Hiroyuki Kobayashi, Masahiro Kizaki, and Yasuo Ikeda; Ribozymes Targeted Against AML1/MTG8: Evaluation of Ribozyme Efficiency in a cell-Free System and Transfection with Cationic Lipsome; Frank Czubayka, Anke M.Schulte, and Anton Wellstein; Ribozyme Targeting of the Growth Factor Pleiotrophin; Thale C. Javis, Dennis Macejak, and Larry Couture; Ribozyme-Mediated Inhibition of Cell Proliferation : A Model for Identifying and Refining a Therapeutic Ribozyme; Mariyn Smedman and Robert B.Denman; Inhibition of βAPP Synthesis by Ribozymes and Oligonucleotides in a Coupled Reticulocyte Transcription Transcription Translation System; Joohun Ha; Selective Modification of Fatty Acid Synthesis Pathway by Expression of an Acetyl-CoA Carboxylase-Specific Ribozyme Gene; S. Petter Lyngstadaas, Brian S Sproat, Martina Biaschke Janos Ludwig, Thomas Rupp, and Hans P. Prydz; In Vivo Knockout of a Tissue-Specific Gene by Synthetic Ribozymes; Shimon Efrat; Ribozyme-Mediated Downregulation of Gene Expression in Transgenic Mice; Yan Yuan and Fenyong Liu; Targeted Cleavage of RNA Using External Guide Sequences and Eukaryotic RNase P; Yan Yuan; Application of In Vitro Selection in Design of External Guide Sequences That Direct Efficient Cleavage of RNA by RNase P; Katalin Kariko and Elliot S. Barnathan; A PCR-Based Approach to Hammerhead Ribozyme Synthesis; P. Kamath and E.J.Shillitoe; Measurement of Ribozyme Activity Using RNase Protection; 447; Index ER -